SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriple Point Ve Regulatory News (TPV)

Share Price Information for Triple Point Ve (TPV)

Share Price is delayed by 15 minutes
Get Live Data
86.00    0.00 (0.00%)
Bid:
84.50
Ask:
87.50
Spread: 3.00 (3.55%)
Market Cap: £114.69m
TPV Live PriceLast checked at - London Stock Exchange

Intraday Triple Point Ve Share Chart

Total Voting Rights

2 Jan 2025 07:00

RNS Number : 7798R
Triple Point Venture VCT PLC
02 January 2025
 

2 January 2025

 

Triple Point Venture VCT Plc

(the "Company")

TOTAL VOTING RIGHTS

 

The following notification is made in accordance with the UK Financial Conduct Authority Disclosure Guidance and Transparency Rule 5.6.1.

 

On 31 December 2024 the issued share capital of the Company was 81,893,444 Venture Shares. The Company does not hold any shares in Treasury. Therefore, the total number of voting rights in the Company is 81,893,444.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

FOR FURTHER INFORMATION ON THE COMPANY, PLEASE CONTACT

 Triple Point Investment Management LLP (Investment Manager)

Tel: 020 7201 8989

 Seb Wallace

 Jack Rose

 

The Company's LEI is 213800AOOAQA5XQDEA89

 

Further information on the Company can be found on its website 

https://www.triplepoint.co.uk/current-vcts/triple-point-venture-vct-plc/s2539/

 

NOTES:

The Company is a Venture Capital Trust incorporated in July 2010 and was established to fund small and medium sized enterprises. The Investment Manager is Triple Point Investment Management LLP.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREAFAFDELLFFA
Date   Source Headline
30th Apr 20262:14 pmRNSTotal Voting Rights
10th Apr 20261:20 pmRNSIssue of Equity and Total Voting Rights
31st Mar 20264:09 pmRNSTotal Voting Rights
31st Mar 20264:05 pmRNSResult of General Meeting
31st Mar 20261:00 pmRNSIssue of Equity and Total Voting Rights
24th Mar 202612:13 pmRNSIssue of Equity and Total Voting Rights
23rd Mar 20267:00 amRNSOffer for Subscription - over-allotment facility
20th Mar 20264:41 pmRNSTransaction in Own Shares
18th Mar 20264:36 pmRNSIssue of Equity and Total Voting Rights
4th Mar 20264:42 pmRNSPublication of a Circular
27th Feb 20264:29 pmRNSTotal Voting Rights
27th Feb 20263:40 pmRNSIssue of Supplementary Prospectus
18th Feb 20265:02 pmRNSProposed Increase in Size of Offer
16th Feb 20262:31 pmRNSISSUE OF EQUITY AND TOTAL VOTING RIGHTS
13th Feb 20264:34 pmRNSOffer for Subscription - over-allotment facility
2nd Feb 20267:00 amRNSNet Asset Value(s)
12th Jan 20267:00 amRNSDividend Declaration
31st Dec 202512:20 pmRNSTotal Voting Rights
31st Dec 202512:20 pmRNSTotal Voting Rights
19th Dec 20257:00 amRNSVenture Share Class Net Asset Value
16th Dec 202512:10 pmRNSIssue of Equity and Total Voting Rights
1st Dec 202512:06 pmRNSIssue of Equity and Total Voting Rights
28th Nov 20259:30 amRNSOffer for Subscription - over-allotment facility
21st Nov 20253:46 pmRNSTransaction in Own Shares
12th Nov 20257:00 amRNSResults for the six months ended 31 August 2025
11th Nov 202511:20 amRNSIssue of Equity and Total Voting Rights
3rd Nov 202510:33 amRNSTotal Voting Rights
14th Oct 202511:14 amRNSIssue of Equity and Total Voting Rights
29th Sep 20257:00 amRNSDividend Declaration
5th Sep 202512:30 pmRNSPublication of a Prospectus
1st Sep 20253:09 pmRNSTotal Voting Rights
8th Aug 20253:23 pmRNSTransaction in Own Shares
4th Aug 20257:00 amRNSIntention to Launch an Offer for Subscription
1st Aug 20259:21 amRNSTotal Voting Rights
31st Jul 20251:27 pmRNSIssue of Equity and Total Voting Rights
30th Jul 20254:29 pmRNSVenture Share Class Net Asset Value
22nd Jul 202511:36 amRNSResult of AGM
4th Jul 20254:28 pmRNSTransaction in Own Shares
4th Jul 20251:16 pmRNSIssue of Equity and Total Voting Rights
25th Jun 20252:44 pmRNSOffer for Subscription - over-allotment facility
24th Jun 20254:36 pmRNSAnnual Financial Report and Notice of AGM
24th Jun 202512:29 pmRNSPublication of Supplementary Prospectus
16th Jun 20257:00 amRNSFinal Results for the year ended 28 February 2025
1st May 20252:58 pmRNSTotal Voting Rights
8th Apr 202510:24 amRNSIssue of Equity and Total Voting Rights
4th Apr 202512:28 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20251:11 pmRNSIssue of Equity and Total Voting Rights
2nd Apr 20251:33 pmRNSTotal Voting Rights
28th Mar 202512:00 pmRNSIssue of Equity and Total Voting Rights
26th Mar 20257:00 amRNSOffer for Subscription - over-allotment facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.